• Site Search
  • Search Local Business Listings
Ann Arbor News Archives

Ann Arbor News Archives Archived news from the Ann Arbor News

Category: Pfizer    RSS

Groups pool $3.5 million to buy former Esperion Therapeutics from Pfizer

By anash

July 23, 2008, 3:54PM
The Michigan Economic Development Corp., the Greater Wayne Economic Development Corp. and a private foundation are pooling $3.5 million to buy the former Esperion Therapeutics headquarters building in Plymouth Township from Pfizer Inc., the groups announced Wednesday. The building will be purchased in Ann Arbor Spark's name, and Spark will run it until a nonprofit group is set up to... Full story »

Pfizer work force in Ann Arbor shrinks to 200

By Douglas D. Fisher

July 02, 2008, 11:58PM
Only 200 Pfizer employees remain working in Ann Arbor as the company stays on track to close its research and development facilities during the fourth quarter, a company spokesman said.  Full story »

Esperion deal keeps important cholesterol research in Michigan

By Steve Pepple

May 01, 2008, 4:03PM
Call it the perfect birthday gift for Roger Newton. On Thursday, the founder of Esperion Therapeutics - a Plymouth Township based biopharmaceutical company that Pfizer bought for $1.3 billion four years ago - announced the company is being revived to continue studying cholesterol drugs. The announcement, which fell on Newton's birthday, came nearly a year after Esperion closed its doors... Full story »

Pfizer selling Esperion Therapeutics division

By anash

May 01, 2008, 11:11AM
Esperion Therapeutics, the biopharmaceutical company that was sold to Pfizer Inc. for $1.3 billion four years ago, is being revived to continue its study of cholesterol drugs. In a statement released early today, Pfizer said it sold its Esperion division, along with selected programs and related assets, to a group of investors. Pfizer is maintaining a financial stake in the... Full story »

Bill & Melinda Gates Foundation may be eyeing Pfizer's Ann Arbor labs

By Steve Pepple

April 18, 2008, 5:56PM
By Stefanie Murray | The Bill & Melinda Gates Foundation appears to be eyeing the soon-to-be-shuttered Pfizer research labs in Ann Arbor. One of the foundation's top executives made mention of the site during a live presentation and Webcast earlier this week with Pfizer Inc. workers in New York City. • Read the story Full story »

Real estate giant toured Pfizer site

By Steve Pepple

March 06, 2008, 7:11PM
By Stefanie Murray | The $10 billion publicly traded national real estate company that recently transformed a former Pfizer Inc. research site in Illinois into a multicompany biotechnology hub confirmed Thursday that it toured the soon-to-be-shuttered Pfizer property in Ann Arbor last year. • Read the story  Full story »

Another donation by Pfizer

By anash

January 22, 2008, 11:00AM
By Tina Reed | Pfizer Inc. announced today that it plans to donate $6.5 million in surplus equipment to Michigan life-sciences companies and research universities. Today also marks the one-year anniversary of Pfizer's announcement that it's Ann Arbor site will close by the end of 2008. • Read the storyOne year later: Pfizer labs emptying outCanter talks about Pfizer transitionResearcher shares view from insidePfizer's loss is other companies' gainEffects of Pfizer closure widespreadVIDEO: Local economic expertOngoing coverage of Pfizer closing Full story »

One year later: Pfizer labs emptying out

By Steve Pepple

January 19, 2008, 6:01PM
By Stefanie Murray | This Tuesday marks the one-year anniversary of Pfizer's stunning announcement that it would close its sprawling research and development facilities in Ann Arbor by the end of 2008. A year ago, Pfizer had 2,100 scientists and researchers working at its Ann Arbor site. Today, those numbers have dwindled to less than 400. • Read the story Full story »

Canter talks about Pfizer transition

By Steve Pepple

January 19, 2008, 5:59PM
Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of Pfizer closure widespread • Ongoing coverage of Pfizer closing Dr. David Canter, who has been head of Pfizer's Ann Arbor site for eight years, talks... Full story »

Pfizer's loss is other companies' gain

By Steve Pepple

January 19, 2008, 5:58PM
"It's been a year of adjustments; I had my first child, lost a job and got a new one." - former Pfizer chemist Nancy Barta. Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of... Full story »

Effects of Pfizer closure widespread

By Steve Pepple

January 19, 2008, 5:21PM
Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of Pfizer closure widespread • Ongoing coverage of Pfizer closing The closing of Pfizer means much more to the community than the loss of more than... Full story »

Researcher shares view from inside

By Steve Pepple

January 19, 2008, 5:02PM
Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of Pfizer closure widespread • Ongoing coverage of Pfizer closing Editor's note: Mary Beth Dunklee, 30, is a resident of Dexter. She is a former Pfizer... Full story »

U-M commits $3 million to help retain Pfizer scientists

By Lynn Monson

March 09, 2007, 7:47AM
University of Michigan President Mary Sue Coleman said U-M will set aside $1 million a year for three years to attract and retain Pfizer scientists as university employees. "We want to make sure it doesn't seem best for people to go away," Coleman told about 300 members of the Ann Arbor business community Thursday at a "Michigan Leaders Speak" forum... Full story »

U-M promises up to $3 million to recruit Pfizer scientists

By Mary McDonough

March 08, 2007, 10:50AM
University of Michigan President Mary Sue Coleman said U-M will set aside $1 million a year for three years to attract and retain Pfizer scientists as university employees. "We want to make sure it doesn't seem best for people to go away," Coleman told about 300 members of the Ann Arbor business community this morning at a "Michigan Leaders Speak"... Full story »

Browse archives »

Inside



Popular Tags